Cuscutae Japonicae Semen Ameliorates Memory Dysfunction by Rescuing Synaptic Damage in Alzheimer's Disease Models
In Gyoung Ju1, Namkwon Kim2, Jin Gyu Choi3
1Department of Life and Nanopharmaceutical Sciences, Graduate school, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Korea. igju801@khu.ac.kr.
Cuscutae Japonicae Semen (CJS) may improve memory and protect synapses in Alzheimer's disease (AD). This study found CJS alleviates cognitive decline and synaptic damage in AD models by inhibiting caspase-3 and related pathways.
Area of Science:
- Neuroscience
- Pharmacology
- Gerontology
Background:
- Alzheimer's disease (AD) is a leading cause of dementia, characterized by amyloid-beta accumulation and cognitive decline.
- Functional foods and nutrients are explored for AD symptom management.
- Cuscutae Japonicae Semen (CJS) is a traditional East Asian medicinal food.
Purpose of the Study:
- To investigate the effects of CJS on memory improvement and synapse protection in Alzheimer's disease models.
- To elucidate the molecular mechanisms underlying CJS's therapeutic potential.
Main Methods:
- Oral administration of CJS to 5xFAD transgenic mice.
- Morris water maze test for memory assessment.
- Analysis of pre- and post-synaptic proteins in mouse hippocampi.
- In vitro studies using primary neuronal cultures treated with amyloid-beta and CJS.
Main Results:
- CJS treatment significantly ameliorated memory decline in 5xFAD mice.
- CJS attenuated the degeneration of synaptic proteins in the hippocampus.
- In vitro, CJS rescued functional synapse loss induced by amyloid-beta.
- CJS inhibited activated caspase-3, glycogen synthase kinase-3β, and tau phosphorylation.
Conclusions:
- Cuscutae Japonicae Semen demonstrates efficacy in alleviating memory loss associated with Alzheimer's disease.
- CJS protects synapses by inhibiting caspase-3-mediated damage and related signaling pathways.
- These findings suggest CJS as a potential therapeutic agent for Alzheimer's disease treatment.
More Related Videos
05:54Author Spotlight: Exploring Acupuncture in Alzheimer's Research from Thread-Embedding Techniques to Clinical Trials
Published on: May 10, 2024
08:01Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits
Published on: March 16, 2016
Related Concept Videos
Alzheimer's Disease: Treatment
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
